Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06036875 · ClinicalTrials.gov registry record
CARE: Cancer Risk Perception and Women of Color
A clinical trial of Breast Carcinoma, sponsored by Mayo Clinic.
- Completed
- Registry status
- 324
- Enrollment target
- 3
- Study locations
NCT06036875: Completed study of Breast Carcinoma, sponsored by Mayo Clinic.
NCT06036875 is a study of Breast Carcinoma that has completed, run by Mayo Clinic. The registered enrollment target is 324 participants, below the 767-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (58% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06036875, a study of Breast Carcinoma, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 324 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study examines patient understanding of current and lifetime risk for breast cancer in women of color from diverse racial and ethnic backgrounds.
Primary Outcome
Measured using a 0-100% response (percent lifetime risk) and a 5-point verbal scale ranging from 'very low' to 'very high' (ordinal lifetime risk). Participants will also be asked to assess their risk compared to women their age with the response options of 'much lower', 'about the same', and 'much higher' (comparative risk likelihood).
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (3)
Arizona
- Mayo Clinic in Arizona - Scottsdale
- University of Arizona - Tucson
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2023-03-25 |
| Est. Completion | 2026-02-27 |
What the finished NCT06036875 record still lists
NCT06036875 is an observational study that tracks outcomes without assigning an intervention. The registered 324 participants enrollment target is mid-sized for trials with a published cap, below the 767-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06036875 reports a single indexed study location in Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT06036875 about?
NCT06036875 is a clinical study titled "CARE: Cancer Risk Perception and Women of Color". This study examines patient understanding of current and lifetime risk for breast cancer in women of color from diverse racial and ethnic backgrounds.
What is the current status of trial NCT06036875?
This trial is currently completed. The enrollment target is 324 participants. The study started on 2023-03-25. Estimated completion is 2026-02-27.
What conditions does trial NCT06036875 study?
This clinical trial studies the following conditions: Breast Carcinoma.
What interventions are being tested in trial NCT06036875?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06036875?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06036875 being conducted?
This trial has 3 study locations across Arizona, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06036875's enrollment target sits among peer trials
324 29th of 106 higher than 78 of 106 other Breast Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surviving Daily Life
RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
RECRUITING
-
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
RECRUITING · Phase 2
-
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
RECRUITING · Phase 2
-
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
RECRUITING
-
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04164173 · 324 participants · NA
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
- NCT04708054 · 324 participants · Phase 2
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- NCT05261399 · 324 participants · Phase 3
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
- NCT05353322 · 324 participants · NA
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI